Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Icía Santos‐Zas"'
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 5 (2019)
Myocardial infarction (MI) is a common condition responsible for mortality and morbidity related to ischemic heart failure. Accumulating experimental and translational evidence support a crucial role for innate immunity in heart failure and adverse h
Externí odkaz:
https://doaj.org/article/bf94231699ef4fa483c61a4e469282fc
Obestatin signalling counteracts glucocorticoid‐induced skeletal muscle atrophy via NEDD4/KLF15 axis
Autor:
Tania Cid‐Díaz, Saúl Leal‐López, Fátima Fernández‐Barreiro, Jessica González‐Sánchez, Icía Santos‐Zas, Luis J. Andrade‐Bulos, Manuel E. Rodríguez‐Fuentes, Carlos S. Mosteiro, Vincent Mouly, Xesús Casabiell, Jose Luis Relova, Yolanda Pazos, Jesus P. Camiña
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 12, Iss 2, Pp 493-505 (2021)
Abstract Background A therapeutic approach for the treatment of glucocorticoid‐induced skeletal muscle atrophy should be based on the knowledge of the molecular mechanisms determining the unbalance between anabolic and catabolic processes and how t
Externí odkaz:
https://doaj.org/article/6aba5e89c5064f319ade19594e974fcf
Obestatin signalling counteracts glucocorticoid‐induced skeletal muscle atrophy via NEDD4/KLF15 axis
Autor:
Vincent Mouly, José Luis Relova, Saul Leal-lopez, Jesus P. Camiña, Manuel E. Rodríguez‐Fuentes, Icía Santos-Zas, Luis J. Andrade‐Bulos, Jessica González-Sánchez, Yolanda Pazos, Carlos S. Mosteiro, Xesús Casabiell, Tania Cid-Díaz, Fátima Fernández‐Barreiro
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle, Vol 12, Iss 2, Pp 493-505 (2021)
Journal of Cachexia, Sarcopenia and Muscle
Journal of Cachexia, Sarcopenia and Muscle, In press, ⟨10.1002/jcsm.12677⟩
Journal of Cachexia, Sarcopenia and Muscle, Wiley Open Access/Springer Verlag, In press, ⟨10.1002/jcsm.12677⟩
Journal of Cachexia, Sarcopenia and Muscle, Wiley Open Access/Springer Verlag, 2021, 12 (2), pp.493-505. ⟨10.1002/jcsm.12677⟩
Journal of Cachexia, Sarcopenia and Muscle
Journal of Cachexia, Sarcopenia and Muscle, In press, ⟨10.1002/jcsm.12677⟩
Journal of Cachexia, Sarcopenia and Muscle, Wiley Open Access/Springer Verlag, In press, ⟨10.1002/jcsm.12677⟩
Journal of Cachexia, Sarcopenia and Muscle, Wiley Open Access/Springer Verlag, 2021, 12 (2), pp.493-505. ⟨10.1002/jcsm.12677⟩
International audience; Background: A therapeutic approach for the treatment of glucocorticoid‐induced skeletal muscle atrophy should be based on the knowledge of the molecular mechanisms determining the unbalance between anabolic and catabolic pro
Autor:
Laurie Soulat-Dufour, Alexandre Boissonnas, Giulia Chinetti, Florence Pinet, Ludivine Laurans, Fabien Lareyre, Andreas Giraud, Léa Guyonnet, Soraya Taleb, Bruno Esposito, Coralie L. Guerin, Marc Derive, Sylvie Lang, Juliette Raffort, José Vilar, Alain Tedgui, Marie Vandestienne, Jean-Sébastien Silvestre, Amir Boufenzer, Hafid Ait-Oufella, Ziad Mallat, Icía Santos-Zas, Rida Al-Rifai, Yujiao Zhang, Patrick Bruneval, Jérémie Joffre, Eric Clauser
Publikováno v:
Journal of Clinical Investigation
Journal of Clinical Investigation, 2021, 131 (2), pp.e142468. ⟨10.1172/JCI142468⟩
J Clin Invest
Journal of Clinical Investigation, 2021, 131 (2), pp.e142468. ⟨10.1172/JCI142468⟩
J Clin Invest
International audience; The triggering receptor expressed on myeloid cells 1 (TREM-1) drives inflammatory responses in several cardiovascular diseases but its role in abdominal aortic aneurysm (AAA) remains unknown. Our objective was to explore the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1eec9b922594c68eee085f5d8a294f04
https://www.hal.inserm.fr/inserm-03833065
https://www.hal.inserm.fr/inserm-03833065
Autor:
Salma Kotti, Alain Tedgui, Marie Vandestienne, Marc Derive, Adrien Georges, François Roubille, Sébastien Gibot, Icía Santos-Zas, Nicolas Danchin, Hafid Ait-Oufella, Nabila Bouatia-Naji, Jérémie Joffre, Denis Angoulvant, Tabassome Simon, Mengyao Yu
Publikováno v:
International Journal of Cardiology
International Journal of Cardiology, In press, S0167-5273 (21), pp.01379-6. ⟨10.1016/j.ijcard.2021.09.018⟩
International Journal of Cardiology, Elsevier, In press, S0167-5273 (21), pp.01379-6. ⟨10.1016/j.ijcard.2021.09.018⟩
International Journal of Cardiology, In press, S0167-5273 (21), pp.01379-6. ⟨10.1016/j.ijcard.2021.09.018⟩
International Journal of Cardiology, Elsevier, In press, S0167-5273 (21), pp.01379-6. ⟨10.1016/j.ijcard.2021.09.018⟩
International audience; Introduction: Triggering receptor expressing on myeloid cells (TREM)-1 is involved in the pathophysiology of ischemic heart disease. Plasma soluble TREM-1 levels (sTREM-1) has been associated with increased risk of major adver
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::819c16e4a81d9c0a7e716c06578ed6c7
https://hal.science/hal-03350417
https://hal.science/hal-03350417
Autor:
Tomás García-Caballero, Yolanda Pazos, Carlos S. Mosteiro, Icía Santos-Zas, Uxía Gurriarán-Rodríguez, Jessica González-Sánchez, Tania Cid-Díaz, Jesus P. Camiña, Xesús Casabiell, Vincent Mouly
Publikováno v:
Journal of Cachexia, Sarcopenia and Muscle. 8:974-990
Background: Many pathological states characterized by muscle atrophy are associated with an increase in circulating glucocorticoids and poor patient prognosis, making it an important target for treatment. The development of treatments for glucocortic
Autor:
Yujiao Zhang, Marie Vandestienne, Jean-Rémi Lavillegrand, Jeremie Joffre, Icia Santos-Zas, Aonghus Lavelle, Xiaodan Zhong, Wilfried Le Goff, Maryse Guérin, Rida Al-Rifai, Ludivine Laurans, Patrick Bruneval, Coralie Guérin, Marc Diedisheim, Melanie Migaud, Anne Puel, Fanny Lanternier, Jean-Laurent Casanova, Clément Cochain, Alma Zernecke, Antoine-Emmanuel Saliba, Michal Mokry, Jean-Sebastien Silvestre, Alain Tedgui, Ziad Mallat, Soraya Taleb, Olivia Lenoir, Cécile Vindis, Stéphane M. Camus, Harry Sokol, Hafid Ait-Oufella
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-17 (2023)
Abstract Caspase recruitment-domain containing protein 9 (CARD9) is a key signaling pathway in macrophages but its role in atherosclerosis is still poorly understood. Global deletion of Card9 in Apoe -/- mice as well as hematopoietic deletion in Ldlr
Externí odkaz:
https://doaj.org/article/b269b498eb06438890385181c12ba8bb
Autor:
José Luis Relova, Tania Cid-Díaz, Carlos Seoane-Mosteiro, Uxía Gurriarán-Rodríguez, Begoña Porteiro, Rosalía Gallego, Jesus P. Camiña, Jessica González-Sánchez, Rubén Nogueiras, Xesús Casabiell, Icía Santos-Zas, Yolanda Pazos, Vincent Mouly
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-1 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-1 (2018)
Obestatin/GPR39 signaling stimulates skeletal muscle growth and repair by inducing both G-protein-dependent and -independent mechanisms linking the activated GPR39 receptor with distinct sets of accessory and effector proteins. In this work, we descr
Autor:
Carlos S. Mosteiro, Tania Cid-Díaz, Rosalía Gallego, Yolanda Pazos, Monica Bouzo-Lorenzo, Xesús Casabiell, Icía Santos-Zas, Vincent Mouly, José Señarís, Felipe F. Casanueva, Uxía Gurriarán-Rodríguez, Jesus P. Camiña, Gabriela Figueroa, Jessica González-Sánchez
Publikováno v:
Cellular and Molecular Life Sciences. 73:617-635
Obestatin/GPR39 signaling stimulates skeletal muscle repair by inducing the expansion of satellite stem cells as well as myofiber hypertrophy. Here, we describe that the obestatin/GPR39 system acts as autocrine/paracrine factor on human myogenesis. O
Autor:
Gillian Butler-Browne, Yolanda Pazos, Elisa Negroni, Rosalía Gallego, Jesus P. Camiña, Icía Santos-Zas, Vincent Mouly, Kamel Mamchaoui, Carlos S. Mosteiro
Publikováno v:
Molecular Therapy
Molecular Therapy, Cell Press, 2017, 25 (10), pp.2345-2359. ⟨10.1016/j.ymthe.2017.06.022⟩
Molecular Therapy, Cell Press, 2017, 25 (10), pp.2345-2359. ⟨10.1016/j.ymthe.2017.06.022⟩
International audience; Although cell-based therapy is considered a promising method aiming at treating different muscular disorders, little clinical benefit has been reported. One of major hurdles limiting the efficiency of myoblast transfer therapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c7f3ac62997fd513a0df041b2d46f35a
https://europepmc.org/articles/PMC5628792/
https://europepmc.org/articles/PMC5628792/